C
Charmacy Pharmaceutical Co Ltd
HKEX:2289
Charmacy Pharmaceutical Co Ltd
HKEX:2289
Price:
14 HKD
Market Closed
Updated:
May 21, 2024
Charmacy Pharmaceutical Co Ltd
Interest Income Expense
|
Charmacy Pharmaceutical Co Ltd
Interest Income Expense Peer Comparison
Comparables:
1099
601607
600998
C
600511
000963
Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
C
|
Charmacy Pharmaceutical Co Ltd
HKEX:2289
|
Interest Income Expense
-¥37m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
N/A
|
|
|
Sinopharm Group Co Ltd
HKEX:1099
|
Interest Income Expense
-¥3.1B
|
CAGR 3-Years
0%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-8%
|
|
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
Interest Income Expense
-¥1.1B
|
CAGR 3-Years
-79%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
N/A
|
|
|
Jointown Pharmaceutical Group Co Ltd
SSE:600998
|
Interest Income Expense
-¥1.2B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-14%
|
|
C
|
China National Medicines Corp Ltd
SSE:600511
|
Interest Income Expense
¥526.1m
|
CAGR 3-Years
25%
|
CAGR 5-Years
26%
|
CAGR 10-Years
23%
|
|
|
Huadong Medicine Co Ltd
SZSE:000963
|
Interest Income Expense
-¥248.5m
|
CAGR 3-Years
-46%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
-20%
|
See Also
What is Charmacy Pharmaceutical Co Ltd's Interest Income Expense?
Interest Income Expense
-37m
CNY
-37m
CNY
Based on the financial report for Dec 31, 2023, Charmacy Pharmaceutical Co Ltd's Interest Income Expense amounts to -37m CNY.
What is Charmacy Pharmaceutical Co Ltd's Interest Income Expense growth rate?
Interest Income Expense CAGR 5Y
-6%
-6%
Over the last year, the Interest Income Expense growth was -18%. The average annual Interest Income Expense growth rates for Charmacy Pharmaceutical Co Ltd have been -10% over the past three years , -6% over the past five years .
You don't have any saved screeners yet
